Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.
Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G. Zanchetti A, et al. Among authors: cifkova r. J Hypertens. 2014 Sep;32(9):1888-97. doi: 10.1097/HJH.0000000000000254. J Hypertens. 2014. PMID: 24979303 Clinical Trial.
Valsartan and atenolol in patients with severe essential hypertension.
Cifkova R, Peleska J, Hradec J, Rosolová H, Pintérová E, Zeman K, Oddou-Stock P, Thirlwell J, Botteri F. Cifkova R, et al. J Hum Hypertens. 1998 Aug;12(8):563-7. doi: 10.1038/sj.jhh.1000615. J Hum Hypertens. 1998. PMID: 9759992 Clinical Trial.
Cyclosporin-induced hypertension.
Cífková R, Hallen H. Cífková R, et al. J Hypertens. 2001 Dec;19(12):2283-5. doi: 10.1097/00004872-200112000-00025. J Hypertens. 2001. PMID: 11725176 No abstract available.
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.
Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Lüscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A; ESH/ESC Hypertension Guidelines Committee. Cifkova R, et al. J Hypertens. 2003 Oct;21(10):1779-86. doi: 10.1097/01.hjh.0000084773.37215.1b. J Hypertens. 2003. PMID: 14508180 No abstract available.
Prevalence, awareness, treatment, and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study.
Cífková R, Skodová Z, Lánská V, Adámková V, Novozámská E, Jozífová M, Plásková M, Hejl Z, Petrzílková Z, Galovcová M, Palous D. Cífková R, et al. J Hum Hypertens. 2004 Aug;18(8):571-9. doi: 10.1038/sj.jhh.1001686. J Hum Hypertens. 2004. PMID: 15002000
308 results